Zhao Chenliang, Chen Rensong, Chen Mian, Liang Xiaoxuan, Ye Jianghai, Zou Juan, Zhang Jingjie
Guizhou Key Laboratory of Miao Medicine, School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Nat Prod Res. 2025 Jul 10:1-7. doi: 10.1080/14786419.2025.2532098.
Nigranoic acid, an A ring-secocycloartene triterpenoid, was constantly found to possess various biological activities, including anti-inflammation. In this study, fifteen new nigranoic acid ester derivatives were synthesised in good yields and assessed for their anti-inflammation activities. As a result, all the compounds including nigranoic acid could reduce NO production considerably ( < 0.001) at a concentration of 50 μM except for compound 12. Among them, compound 7 showed more NO inhibition potency than others with a concentration of 9.7 μmol/mL and minimal cytotoxicity (cell viability: 100%) in RAW 264.7 cells. Moreover, compound 7 may regulate PTGS2 and NFE2L2 to affect its anti-inflammatory activity through the network pharmacology and molecular docking analysis, indicating its potential as an anti-inflammatory candidate.
尼格拉诺酸是一种A环-断环环阿尔廷三萜类化合物,一直被发现具有多种生物活性,包括抗炎作用。在本研究中,以良好的产率合成了15种新的尼格拉诺酸酯衍生物,并对其抗炎活性进行了评估。结果,除化合物12外,包括尼格拉诺酸在内的所有化合物在50μM浓度下均可显著降低NO生成量(<0.001)。其中,化合物7在RAW 264.7细胞中浓度为9.7μmol/mL时表现出比其他化合物更强的NO抑制能力,且细胞毒性最小(细胞活力:100%)。此外,通过网络药理学和分子对接分析,化合物7可能调节PTGS2和NFE2L2以影响其抗炎活性,表明其作为抗炎候选药物的潜力。